Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50,349 | 16 | 71.1% |
| Consulting Fee | $13,913 | 9 | 19.6% |
| Food and Beverage | $4,220 | 102 | 6.0% |
| Travel and Lodging | $2,311 | 20 | 3.3% |
| Education | $55.50 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $61,522 | 83 | $0 (2021) |
| Allergan Inc. | $6,521 | 6 | $0 (2017) |
| Medtronic USA, Inc. | $618.91 | 7 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $535.58 | 28 | $0 (2024) |
| Biogen, Inc. | $450.00 | 2 | $0 (2019) |
| Genentech USA, Inc. | $178.33 | 3 | $0 (2018) |
| Abbott Laboratories | $139.70 | 1 | $0 (2024) |
| UCB, Inc. | $137.39 | 3 | $0 (2024) |
| Lilly USA, LLC | $130.84 | 7 | $0 (2019) |
| Amgen Inc. | $125.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $320.46 | 4 | Abbott Laboratories ($139.70) |
| 2023 | $334.52 | 4 | Mirati Therapeutics, Inc. ($125.00) |
| 2022 | $153.91 | 8 | Janssen Pharmaceuticals, Inc ($153.91) |
| 2021 | $179.54 | 4 | GENZYME CORPORATION ($125.00) |
| 2019 | $366.24 | 14 | Biogen, Inc. ($150.00) |
| 2018 | $11,324 | 40 | GENZYME CORPORATION ($10,631) |
| 2017 | $58,169 | 78 | GENZYME CORPORATION ($50,766) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $111.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/01/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Food and Beverage | In-kind items and services | $139.70 | General |
| Category: Structural Heart | ||||||
| 01/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $49.97 | General |
| Category: Neurology | ||||||
| 10/27/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $122.10 | General |
| Category: Neurology | ||||||
| 10/17/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $45.55 | General |
| Category: Neurology | ||||||
| 10/04/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $41.87 | General |
| Category: Neurology | ||||||
| 04/11/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/06/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/31/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2021 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 05/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/03/2019 | Lilly USA, LLC | — | Education | In-kind items and services | $1.00 | General |
| 09/20/2019 | Biogen, Inc. | TYSABRI (Biological) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: NEUROLOGY | ||||||
| 08/20/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/23/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 271 | 328 | $115,927 | $30,620 |
| 2022 | 3 | 148 | 188 | $113,595 | $19,564 |
| 2021 | 7 | 334 | 386 | $234,644 | $43,008 |
| 2020 | 6 | 336 | 391 | $241,320 | $45,877 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 84 | 85 | $36,011 | $9,098 | 25.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 62 | 64 | $33,408 | $8,974 | 26.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 86 | 123 | $29,459 | $7,833 | 26.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 42 | $13,566 | $4,090 | 30.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 14 | 14 | $3,483 | $625.66 | 18.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 81 | 120 | $63,032 | $9,552 | 15.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 52 | 53 | $42,628 | $8,272 | 19.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 15 | 15 | $7,935 | $1,740 | 21.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 120 | 124 | $104,519 | $19,703 | 18.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 123 | 168 | $90,384 | $13,911 | 15.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 16 | 16 | $8,640 | $2,499 | 28.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 20 | $11,896 | $2,172 | 18.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 17 | 18 | $7,056 | $2,098 | 29.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 25 | 26 | $8,568 | $1,465 | 17.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 14 | $3,581 | $1,159 | 32.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 130 | 133 | $111,636 | $22,019 | 19.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 122 | 172 | $89,498 | $14,586 | 16.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 27 | 27 | $14,148 | $3,884 | 27.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 23 | 23 | $12,798 | $2,564 | 20.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 19 | 20 | $8,256 | $1,874 | 22.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 16 | $4,984 | $949.86 | 19.1% |
About Dr. Sunil Chauhan, MD
Dr. Sunil Chauhan, MD is a Neurology healthcare provider based in Stuart, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912922881.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sunil Chauhan, MD has received a total of $70,847 in payments from pharmaceutical and medical device companies, with $320.46 received in 2024. These payments were reported across 152 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($50,349).
As a Medicare-enrolled provider, Chauhan has provided services to 1,089 Medicare beneficiaries, totaling 1,293 services with total Medicare billing of $139,068. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Stuart, FL
- Active Since 07/13/2006
- Last Updated 06/30/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1912922881
Products in Payments
- LEMTRADA (Drug) $41,865
- AUBAGIO (Drug) $12,130
- DISEASE STATE (Drug) $7,392
- BOTOX (Biological) $6,435
- ACTIVA (Device) $618.91
- XARELTO (Drug) $535.58
- ZINBRYTA (Biological) $300.00
- TYSABRI (Biological) $150.00
- AMPLATZER TALISMAN (Device) $139.70
- Briviact (Drug) $137.39
- KRAZATI (Drug) $125.00
- SARCLISA (Biological) $125.00
- Leqembi (Drug) $122.10
- ACTHAR (Biological) $88.99
- BOTOX NEURO REHAB (Drug) $74.33
- NO PRODUCT DISCUSSED (Drug) $44.00
- ELIQUIS (Drug) $43.54
- EMGALITY (Drug) $40.27
- TROKENDI XR (Drug) $31.50
- CHANTIX (Drug) $17.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Stuart
Dr. Lara Fix, Do, DO
Neurology — Payments: $20,772
Henry Calas, Md, MD
Neurology — Payments: $20,459
Paul Elliott, Do, DO
Neurology — Payments: $19,557
Daniela Saadia, Md, MD
Neurology — Payments: $11,772
Alyssa Starek, Pa, PA
Neurology — Payments: $8,458
Joshua Leibner, M.d, M.D
Neurology — Payments: $2,533